Peptides and Pancreatitis: Pancreatic Recovery Research
Pancreatitis has few treatment options. Preclinical research on BPC-157 shows consistent protective effects in pancreatic injury models. A review of the evidence.
-
-
Follistatin (FST-344): Myostatin Inhibition, Muscle & Gene Therapy Research
What Is Follistatin? Follistatin is a naturally occurring glycoprotein that functions as a binding protein and inhibitor of members of the TGF-β (transforming growth factor-beta) superfamily — most notably activin and myostatin.
-
LL-37: Antimicrobial Peptide Research, Immune Defense & Wound Healing
What Is LL-37? LL-37 is the only cathelicidin antimicrobial peptide produced by the human body. It is a 37-amino-acid peptide (beginning with two leucine residues, hence “LL”) derived from the precursor protein hCAP18 (human cationic antimicrobial protein of 18 kDa), which is…
-
5-Amino-1MQ: NNMT Inhibitor, Fat Metabolism & Metabolic Research Guide
What Is 5-Amino-1MQ? 5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT).
-
How to Track Your Peptide Research Results Effectively
Good tracking separates useful peptide research from anecdote. A step-by-step guide to baseline measurement, tracking frequency, variable control, and result analysis.
-
Peptides and Gallbladder Health: What We Know
The gallbladder connects closely to gut and liver systems where BPC-157 has shown protective effects. What does research say about peptides and biliary health?
-
Peptides and Hepatitis: Immune and Liver Support Research
Thymosin Alpha-1 has clinical trial data for Hepatitis B and C. Glutathione and BPC-157 offer hepatoprotective research context. Here’s the science on peptides and hepatitis.
-
Peptides vs PRP: Which Has More Evidence for Healing?
PRP and research peptides like BPC-157, TB-500, and GHK-Cu are both studied for tissue healing. A side-by-side comparison of the evidence base for each approach.
-
Peptides and Fatty Liver / NASH: Research on Hepatoprotection
NAFLD and NASH affect 25% of adults globally. Research on BPC-157 and Glutathione shows hepatoprotective effects in preclinical models — here’s what the evidence shows.
-
Peptides and Liver Detox: What the Science Actually Says
BPC-157, Glutathione, and NAD+ have all been researched for hepatoprotective effects. Here’s what the science actually shows — and where the evidence stops.